Please Wait...

DIA’s 21st Annual Workshop in Japan for Clinical Data Management

February 19, 2018 - 1:00am (EST) to February 20, 2018 - 1:00am (EST)

Join Bioclinica’s Chief Commercial Officer David Kiger at DIA Japan in Tokyo where he will present a special topic on February 20 at 16:30 in Session 6: Data Management in Investigator-Initiated Clinical Trials and Clinical Research.

 

Session Co-Chairs:

Akimitsu Ikeura, Manager, Data Management Group, Biostatistics & Data Management Dept., Daiichi Sankyo Co., Ltd.

Kyoko Minamoto, Clinical Data Manager, Clinical Research Support Center, The University of Tokyo Hospital

After the Pharmaceutical Affairs Law was revised in 2003, investigators and pharmaceutical companies could plan and conduct clinical trials themselves. In the 15 years since passed, compliance with CDISC and other international standards has become indispensable, and individual investigators have increasingly needed to secure funds and other resources from external sources. It is now expected that academic clinical research will be effected by the new Act on Clinical Studies published in April 2017. This session will discuss anticipated developments impacting investigator-initiated clinical trials in academia.

 

Unstructured and Structured Big Data Convergence for Bridging Clinical, Regulatory, and Commercialization

David Kiger, Chief Commercial Officer, Bioclinica

 

Data Management in Pharmaceutical industry and Academia (tentative)

Mikio Mori, Section Head, Data Management Section, Data Management Division, Clinical Research Support Office, National Cancer Center Hospital

 

New Act on Clinical Studies (tentative)

Yasuhiro Fujiwara, MD, PhD, Director General, Strategic Planning Bureau, National Cancer Center

 

Visit Event Website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (Yesterday)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (5 days ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (5 days ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (5 days ago)
RT @FDA_Drug_Info: Read our report “Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017” to lea…
bioclinica (5 days ago)
RT @CDISC: Join us for CDISC's first public webinar of 2018 - Controlled Terminology Quarterly Updates https://t.co/2EbR3X9TsG
bioclinica (5 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen